Should you buy Moderna stock today?

Moderna shares have declined more than 50% this year, leaving them trading at about 8.5 times forward earnings estimates, which is a steal -- even if Moderna only makes it part of the way to its product launch goal. And if it does attain its launch target and you buy the stock today, you may be setting yourself up for significant gains over time.

Where is Moderna headquartered?

Biotech leader Moderna, which has developed a Covid-19 vaccine, is headquartered at 200 Technology Square, in Cambridge. Moderna Inc. is changing up its executive team and restructuring, but it's offering few details as to what that will entail.

Will Moderna become a two-product company?

Though two other RSV vaccines exist on the commercial market, Moderna's would be the only one available in a prefilled syringe; this ease of use could give it the upper hand. If all goes well during the regulatory review, Moderna may become a two-product company in a matter of months. Now let's consider the personalized cancer vaccine candidate.

Does Moderna's new data help build a case for cancer treatment?

Moderna on Thursday unveiled new data from a continuing early-stage trial of the personalized cancer treatment it is testing with Merck, saying that the updated results help build the case that the drug works.